TBPH

TBPH

USD

Theravance Biopharma Inc. Ordinary Shares

$14.750-0.110 (-0.740%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$14.860

Hoch

$15.001

Tief

$14.420

Volumen

0.49M

Unternehmensfundamentaldaten

Marktkapitalisierung

742.8M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.42M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $7.9Aktuell $14.750Hoch $15.335

Ähnliche Nachrichten

PR Newswire

Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System

Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will be participating at the 36th International Symposium on the Autonomic Nervous...

Mehr anzeigen
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
PR Newswire

Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025

Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2025 financial results and provide a business update after market close on...

Mehr anzeigen
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire...

Mehr anzeigen
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.